Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients

Clinical trial NCT04205552 · COMPLETED

Trial details

NCT number: NCT04205552
Sponsor: University Hospital, Essen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Stage II NSCLC, Stage IIIA NSCLC, Stage I

Start date: 2020-03-04
Primary completion: 2025-11-27
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.